SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Merz Aesthetics (Formerly Known as BioForm Medical, Inc.) Announces FDA Approval of XEOMIN(R) (incobotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines in Adult Patients